Published in Hepatitis Weekly, November 13th, 2000
"HBsAg [hepatitis B surface antigen] encoded in eukaryotically expressed plasmids has been documented to elicit good humoral and cellular immune responses when injected in animals, and is a good candidate for immunization of non-responders of recombinant HBsAg vaccines and for therapeutic vaccination," stated L.P. Wong and colleagues from the University of Hong Kong. "Live-attenuated Salmonella is safe to be administered orally, and has been shown to be able to deliver DNA vaccines. [We sought] to evaluate the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly